Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: J Thorac Oncol. 2010 Aug;5(8):1279–1284. doi: 10.1097/JTO.0b013e3181e2fcb0

Figure 1.

Figure 1

Numbers of circulating endothelial cells (defined as CD45NEG, CD146POS, CD133NEG and DAPI bright with viable nuclei), with Day 1 draw immediately prior to initiation of first cycle of treatment and the final draw at time of disease progression.